| Titolo |
Pubblicato in |
Anno |
| Risankizumab versus Secukinumab: a real-world efficacy and cost per responder comparison in patients with psoriasis in Italy |
DERMATOLOGY PRACTICAL & CONCEPTUAL |
2025 |
| Efficacy and safety of intra-class switching from Ixekizumab to Secukinumab in patients with plaque psoriasis. A multicenter retrospective study |
JOURNAL OF PERSONALIZED MEDICINE |
2024 |
| Ramsay Hunt Syndrome in an Epileptic Patient |
SKINMED |
2022 |
| Biosimilar versus originator etanercept: a real-life clinical study |
ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY |
2022 |
| Risankizumab for the treatment of moderate-to-severe psoriasis. A multicenter, retrospective, 1 year real-life study |
DERMATOLOGIC THERAPY |
2022 |
| Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis. A Case Report |
CASE REPORTS IN DERMATOLOGY |
2021 |
| Alopecia areata in a COVID-19 patient. A case report |
DERMATOLOGIC THERAPY |
2021 |
| Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy |
EXPERT OPINION ON BIOLOGICAL THERAPY |
2021 |
| Treatment of refractory conjunctivitis associated to dupilumab with topical pimecrolimus applied to the eyelid skin |
DERMATOLOGIC THERAPY |
2019 |
| Reed syndrome: A case report and dermatoscopic features |
JOURNAL OF COSMETIC DERMATOLOGY |
2019 |
| Tridimensional matryoshka tattoo. an important |
ACTA DERMATOVENEROLOGICA CROATICA |
2019 |
| A successful topical treatment for cutaneous inflammatory diseases: an additional or alternative therapy to topical steroids |
EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY |
2019 |
| The relationships between health-related quality of life, illness severity, personality and psychiatric symptoms in patients with psoriasis |
RESEARCH IN PSYCHOTHERAPY |
2018 |
| EPITELIOMA BASOCELLULARE: UN TUMORE RARO A LIVELLO DEL PIEDE |
IL PODOLOGO IN MEDICINA |
2017 |
